γ-Secretase in biology and medicine

Goedert, 2006, A century of Alzheimer's disease, Science, 314, 777, 10.1126/science.1132814 Cole, 2008, The role of APP processing by BACE1, the beta-secretase, in Alzheimer's disease pathophysiology, J Biol Chem, 23, 23 Weidemann, 2002, A novel var epsilon-cleavage within the transmembrane domain of the Alzheimer amyloid precursor protein demonstrates homology with Notch processing, Biochemistry, 41, 2825, 10.1021/bi015794o Tanzi, 2005, Twenty years of the Alzheimer's disease amyloid hypothesis: a genetic perspective, Cell, 120, 545, 10.1016/j.cell.2005.02.008 Hardy, 1997, The Alzheimer family of diseases: many etiologies, one pathogenesis?, Proc Natl Acad Sci USA, 94, 2095, 10.1073/pnas.94.6.2095 De Strooper, 1998, Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein, Nature, 391, 387, 10.1038/34910 Wolfe, 1999, Peptidomimetic probes and molecular modeling suggest Alzheimer's γ-secretases are intramembrane-cleaving aspartyl proteases, Biochemistry, 38, 4720, 10.1021/bi982562p Wolfe, 1999, Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and γ-secretase activity, Nature, 398, 513, 10.1038/19077 Thinakaran, 1997, Evidence that levels of presenilins (PS1 and PS2) are coordinately regulated by competition for limiting cellular factors, J Biol Chem, 272, 28415, 10.1074/jbc.272.45.28415 Ratovitski, 1997, Endoproteolytic processing and stabilization of wild-type and mutant presenilin, J Biol Chem, 272, 24536, 10.1074/jbc.272.39.24536 Yu, 1998, The presenilin 1 protein is a component of a high molecular weight intracellular complex that contains beta-catenin, J Biol Chem, 273, 16470, 10.1074/jbc.273.26.16470 Laudon, 2004, Co-expressed presenilin 1 NTF and CTF form functional gamma-secretase complexes in cells devoid of full-length protein, J Neurochem, 89, 44, 10.1046/j.1471-4159.2003.02298.x Li, 2000, Photoactivated gamma-secretase inhibitors directed to the active site covalently label presenilin 1, Nature, 405, 689, 10.1038/35015085 Esler, 2000, Transition-state analogue inhibitors of γ-secretase bind directly to presenilin-1, Nat Cell Biol, 2, 428, 10.1038/35017062 De Strooper, 1999, A presenilin-1-dependent γ-secretase-like protease mediates release of Notch intracellular domain, Nature, 398, 518, 10.1038/19083 Levitan, 1995, Facilitation of lin-12-mediated signaling by sel-12, a Caenorhabditis elegans S182 Alzheimer's gene, Nature, 377, 351, 10.1038/377351a0 Schroeter, 1998, Notch-1 signalling requires ligand-induced proteolytic release of intracellular domain, Nature, 393, 382, 10.1038/30756 Huppert, 2000, Embryonic lethality in mice homozygous for a processing-deficient allele of Notch1, Nature, 405, 966, 10.1038/35016111 Kopan, 2004, Gamma-secretase: proteasome of the membrane?, Nat Rev Mol Cell Biol, 5, 499, 10.1038/nrm1406 Marambaud, 2003, A CBP binding transcriptional repressor produced by the PS1/epsilon-cleavage of N-cadherin is inhibited by PS1 FAD mutations, Cell, 114, 635, 10.1016/j.cell.2003.08.008 Sardi, 2006, Presenilin-dependent ErbB4 nuclear signaling regulates the timing of astrogenesis in the developing brain, Cell, 127, 185, 10.1016/j.cell.2006.07.037 Wolfe, 2004, Intramembrane proteolysis: theme and variations, Science, 305, 1119, 10.1126/science.1096187 De Strooper, 2003, Aph-1, Pen-2, and Nicastrin with Presenilin generate an active gamma-Secretase complex, Neuron, 38, 9, 10.1016/S0896-6273(03)00205-8 Spasic, 2008, Building gamma-secretase: the bits and pieces, J Cell Sci, 121, 413, 10.1242/jcs.015255 Yu, 2000, Nicastrin modulates presenilin-mediated notch/glp-1 signal transduction and betaAPP processing, Nature, 407, 48, 10.1038/35024009 Francis, 2002, aph-1 and pen-2 are required for Notch pathway signaling, gamma-secretase cleavage of betaAPP, and presenilin protein accumulation, Dev Cell, 3, 85, 10.1016/S1534-5807(02)00189-2 Takasugi, 2003, The role of presenilin cofactors in the gamma-secretase complex, Nature, 422, 438, 10.1038/nature01506 Kimberly, 2003, γ-Secretase is a membrane protein complex comprised of presenilin, nicastrin, aph-1, and pen-2, Proc Natl Acad Sci USA, 100, 6382, 10.1073/pnas.1037392100 Edbauer, 2003, Reconstitution of gamma-secretase activity, Nat Cell Biol, 5, 486, 10.1038/ncb960 Hayashi, 2004, Selective reconstitution and recovery of functional gamma-secretase complex on budded baculovirus particles, J Biol Chem, 279, 38040, 10.1074/jbc.M405597200 Zhang, 2005, Characterization of the reconstituted gamma-secretase complex from Sf9 cells co-expressing presenilin 1, nicastrin [correction of nacastrin], aph-1a, and pen-2, Biochemistry, 44, 4450, 10.1021/bi0481500 Fraering, 2004, Purification and characterization of the human gamma-secretase complex, Biochemistry, 43, 9774, 10.1021/bi0494976 Wolfe, 2006, The gamma-secretase complex: membrane-embedded proteolytic ensemble, Biochemistry, 45, 7931, 10.1021/bi060799c Steiner, 2008, Chemical crosslinking provides a model of the gamma -secretase complex subunit architecture and evidence for close proximity of the C-terminal fragment of presenilin with APH-1, J Biol Chem, 83, 34677, 10.1074/jbc.M709067200 Wolfe, 1999, Are presenilins intramembrane-cleaving proteases? Implications for the molecular mechanism of Alzheimer's disease, Biochemistry, 38, 11223, 10.1021/bi991080q Esler, 2002, Activity-dependent isolation of the presenilin/γ-secretase complex reveals nicastrin and a γ substrate, Proc Natl Acad Sci USA, 99, 2720, 10.1073/pnas.052436599 Das, 2003, Designed helical peptides inhibit an intramembrane protease, J Am Chem Soc, 125, 11794, 10.1021/ja037131v Kornilova, 2005, The initial substrate-binding site of gamma-secretase is located on presenilin near the active site, Proc Natl Acad Sci USA, 102, 3230, 10.1073/pnas.0407640102 Bihel, 2004, Discovery of a subnanomolar helical D-tridecapeptide inhibitor of γ-secretase, J Med Chem, 47, 3931, 10.1021/jm049788c Shah, 2005, Nicastrin functions as a gamma-secretase-substrate receptor, Cell, 122, 435, 10.1016/j.cell.2005.05.022 Chavez-Gutierrez, 2008, Glu 332 in the Nicastrin ectodomain is essential for gamma -Secretase complex maturation but not for its activity, J Biol Chem, 283, 20096, 10.1074/jbc.M803040200 Dovey, 2001, Functional gamma-secretase inhibitors reduce beta-amyloid peptide levels in brain, J Neurochem, 76, 173, 10.1046/j.1471-4159.2001.00012.x Lanz, 2003, The gamma-secretase inhibitor N-[N-(3,5-difluorophenacetyl)-L-alanyl]-S-phenylglycine t-butyl ester reduces A beta levels in vivo in plasma and cerebrospinal fluid in young (plaque-free) and aged (plaque-bearing) Tg2576 mice, J Pharmacol Exp Ther, 305, 864, 10.1124/jpet.102.048280 Barten, 2005, Dynamics of {beta}-amyloid reductions in brain, cerebrospinal fluid and plasma of {beta}-amyloid precursor protein transgenic mice treated with a {gamma}-secretase inhibitor, J Pharmacol Exp Ther, 312, 635, 10.1124/jpet.104.075408 Anderson, 2005, Reductions in beta-amyloid concentrations in vivo by the gamma-secretase inhibitors BMS-289948 and BMS-299897, Biochem Pharmacol, 69, 689, 10.1016/j.bcp.2004.11.015 Best, 2005, Quantitative measurement of changes in amyloid-beta(40) in the rat brain and cerebrospinal fluid following treatment with the gamma-secretase inhibitor LY-411575 [N2-[(2S)-2-(3,5-difluorophenyl)-2-hydroxyethanoyl]-N1-[(7S)-5-methyl-6-ox o-6,7-dihydro-5H-dibenzo[b,d]azepin-7-yl]-L-alaninamide], J Pharmacol Exp Ther, 313, 902, 10.1124/jpet.104.081174 Siemers, 2005, Safety, tolerability, and changes in amyloid beta concentrations after administration of a gamma-secretase inhibitor in volunteers, Clin Neuropharmacol, 28, 126, 10.1097/01.wnf.0000167360.27670.29 Siemers, 2006, Effects of a gamma-secretase inhibitor in a randomized study of patients with Alzheimer disease, Neurology, 66, 602, 10.1212/01.WNL.0000198762.41312.E1 Siemers, 2007, Safety, tolerability, and effects on plasma and cerebrospinal fluid amyloid-beta after inhibition of gamma-secretase, Clin Neuropharmacol, 30, 317, 10.1097/WNF.0b013e31805b7660 Wong, 1997, Presenilin 1 is required for Notch1 and DII1 expression in the paraxial mesoderm, Nature, 387, 288, 10.1038/387288a0 Shen, 1997, Skeletal and CNS defects in Presenilin-1-deficient mice, Cell, 89, 629, 10.1016/S0092-8674(00)80244-5 Selkoe, 2003, Notch and Presenilin: regulated intramembrane proteolysis links development and degeneration, Annu Rev Neurosci, 26, 565, 10.1146/annurev.neuro.26.041002.131334 Searfoss, 2003, Adipsin: a biomarker of gastrointestinal toxicity mediated by a functional gamma secretase inhibitor, J Biol Chem, 29, 29 Wong, 2004, Chronic treatment with the gamma-secretase inhibitor LY-411,575 inhibits beta-amyloid peptide production and alters lymphopoiesis and intestinal cell differentiation, J Biol Chem, 279, 12876, 10.1074/jbc.M311652200 Weggen, 2001, A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity, Nature, 414, 212, 10.1038/35102591 Weggen, 2003, Evidence that nonsteroidal anti-inflammatory drugs decrease amyloid beta 42 production by direct modulation of gamma-secretase activity, J Biol Chem, 278, 31831, 10.1074/jbc.M303592200 Beher, 2004, Selected non-steroidal anti-inflammatory drugs and their derivatives target gamma-secretase at a novel site. Evidence for an allosteric mechanism, J Biol Chem, 279, 43419, 10.1074/jbc.M404937200 Okochi, 2006, Secretion of the Notch-1 Abeta-like peptide during Notch signaling, J Biol Chem, 281, 7890, 10.1074/jbc.M513250200 Kukar, 2007, Chronic administration of R-flurbiprofen attenuates learning impairments in transgenic amyloid precursor protein mice, BMC Neurosci, 8, 54, 10.1186/1471-2202-8-54 Galasko, 2007, Safety, tolerability, pharmacokinetics, and Abeta levels after short-term administration of R-flurbiprofen in healthy elderly individuals, Alzheimer Dis Assoc Disord, 21, 292, 10.1097/WAD.0b013e31815d1048 Kukar, 2008, Substrate-targeting gamma-secretase modulators, Nature, 453, 925, 10.1038/nature07055 Imbimbo, 2007, 1-(3’,4’-Dichloro-2-fluoro[1,1’-biphenyl]-4-yl)-cyclopropanecarboxylic acid (CHF5074), a novel gamma-secretase modulator, reduces brain beta-amyloid pathology in a transgenic mouse model of Alzheimer's disease without causing peripheral toxicity, J Pharmacol Exp Ther, 323, 822, 10.1124/jpet.107.129007 Jantzen, 2002, Microglial activation and beta -amyloid deposit reduction caused by a nitric oxide-releasing nonsteroidal anti-inflammatory drug in amyloid precursor protein plus presenilin-1 transgenic mice, J Neurosci, 22, 2246, 10.1523/JNEUROSCI.22-06-02246.2002 Netzer, 2003, Gleevec inhibits beta-amyloid production but not Notch cleavage, Proc Natl Acad Sci USA, 100, 12444, 10.1073/pnas.1534745100 Fraering, 2005, gamma -Secretase substrate selectivity can be modulated directly via interaction with a nucleotide binding site, J Biol Chem, 280, 41987, 10.1074/jbc.M501368200 Mayer, 2008, Discovery of begacestat, a Notch-1-sparing gamma-secretase inhibitor for the treatment of Alzheimer's disease, J Med Chem, 10.1021/jm801252w Shih Ie, 2007, Notch signaling, gamma-secretase inhibitors, and cancer therapy, Cancer Res, 67, 1879, 10.1158/0008-5472.CAN-06-3958 Grabher, 2006, Notch 1 activation in the molecular pathogenesis of T-cell acute lymphoblastic leukaemia, Nat Rev Cancer, 6, 347, 10.1038/nrc1880 Weng, 2004, Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia, Science, 306, 269, 10.1126/science.1102160 Dang, 2000, Chromosome 19 translocation, overexpression of Notch3, and human lung cancer, J Natl Cancer Inst, 92, 1355, 10.1093/jnci/92.16.1355 Park, 2006, Notch3 gene amplification in ovarian cancer, Cancer Res, 66, 6312, 10.1158/0008-5472.CAN-05-3610 Gallahan, 1997, The mouse mammary tumor associated gene INT3 is a unique member of the NOTCH gene family (NOTCH4), Oncogene, 14, 1883, 10.1038/sj.onc.1201035 Curry, 2005, Gamma secretase inhibitor blocks Notch activation and induces apoptosis in Kaposi's sarcoma tumor cells, Oncogene, 24, 6333, 10.1038/sj.onc.1208783 Hallahan, 2004, The SmoA1 mouse model reveals that notch signaling is critical for the growth and survival of sonic hedgehog-induced medulloblastomas, Cancer Res, 64, 7794, 10.1158/0008-5472.CAN-04-1813 O’Neil, 2006, Activating Notch1 mutations in mouse models of T-ALL, Blood, 107, 781, 10.1182/blood-2005-06-2553 Zeng, 2005, Crosstalk between tumor and endothelial cells promotes tumor angiogenesis by MAPK activation of Notch signaling, Cancer Cell, 8, 13, 10.1016/j.ccr.2005.06.004 Wang, 2008, Emerging role of Notch in stem cells and cancer, Cancer Lett